Stock ACUT ACCUSTEM SCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials AccuStem Sciences, Inc.

Equities

ACUT

US00444A1016

Medical Equipment, Supplies & Distribution

Market Closed - OTC Markets
Other stock markets
 09:30:01 2024-05-23 EDT 		5-day change 1st Jan Change
0.277 USD -20.86% Intraday chart for AccuStem Sciences, Inc. 0.00% -55.73%
05-20 AccuStem Sciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
03-22 AccuStem Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 15.31 7.1
Enterprise Value (EV) 2 14.68 7.134
P/E ratio -3.97 x -3.46 x
Yield - -
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA -3,921,429 x -3,484,907 x
EV / FCF -18,580,753 x 66,438,095 x
FCF Yield -0% 0%
Price to Book -110 x -3.36 x
Nbr of stocks (in thousands) 11,338 11,347
Reference price 3 1.350 0.6257
Announcement Date 2/15/23 3/22/24
1USD in Million2GBP in Million3USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales - - - -
EBITDA - - -3.743 -2.047
EBIT 1 -0.0698 -0.6706 -3.746 -2.051
Operating Margin - - - -
Earnings before Tax (EBT) 1 -0.0698 -0.6706 -3.746 -2.051
Net income 1 -0.0698 -0.6706 -3.746 -2.051
Net margin - - - -
EPS - -0.0671 -0.3401 -0.1807
Free Cash Flow - -1.104 -0.79 0.1074
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 3/12/21 2/15/23 2/15/23 3/22/24
1GBP in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt 1 - - - 0.03
Net Cash position 1 1.15 - 0.63 -
Leverage (Debt/EBITDA) - - - -0.0167 x
Free Cash Flow - -1.1 -0.79 0.11
ROE (net income / shareholders' equity) - -27% -1,466% 182%
ROA (Net income/ Total Assets) - -14.7% -204% -239%
Assets 1 - 4.577 1.834 0.8589
Book Value Per Share 2 0.3100 0.0700 -0.0100 -0.1900
Cash Flow per Share 2 0.1100 - 0.0600 0
Capex - - 0.01 -
Capex / Sales - - - -
Announcement Date 3/12/21 2/15/23 2/15/23 3/22/24
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
ACCUSTEM SCIENCES, INC. Stock AccuStem Sciences, Inc.
-55.73% 3.14M
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.31% 181B
MEDTRONIC PLC Stock Medtronic plc
-1.21% 108B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-5.53% 66.57B
DEXCOM, INC. Stock DexCom, Inc.
+1.22% 49.95B
CENCORA, INC. Stock Cencora, Inc.
+7.03% 43.84B
HOYA CORPORATION Stock Hoya Corporation
+4.91% 41.71B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+21.96% 31.59B
TERUMO CORPORATION Stock Terumo Corporation
+14.45% 25.3B
ZIMMER BIOMET HOLDINGS, INC. Stock Zimmer Biomet Holdings, Inc.
-4.81% 23.83B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. ACUT Stock
  4. Financials AccuStem Sciences, Inc.